Suppr超能文献

初治多发性硬化症患者脑脊液 B 细胞的克隆关系。

Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.

出版信息

JCI Insight. 2017 Nov 16;2(22). doi: 10.1172/jci.insight.92724.

Abstract

A role of B cells in multiple sclerosis (MS) is well established, but there is limited understanding of their involvement during active disease. Here, we examined cerebrospinal fluid (CSF) and peripheral blood (PB) B cells in treatment-naive patients with MS or high-risk clinically isolated syndrome. Using flow cytometry, we found increased CSF lymphocytes with a disproportionate increase of B cells compared with T cells in patients with gadolinium-enhancing (Gd+) lesions on brain MRI. Ig gene heavy chain variable region (Ig-VH) repertoire sequencing of CSF and PB B cells revealed clonal relationships between intrathecal and peripheral B cell populations, which could be consistent with migration of B cells to and activation in the CNS in active MS. In addition, we found evidence for bystander immigration of B cells from the periphery, which could be supported by a CXCL13 gradient between CSF and blood. Understanding what triggers B cells to migrate and home to the CNS may ultimately aid in the rational selection of therapeutic strategies to limit progression in MS.

摘要

B 细胞在多发性硬化症(MS)中的作用已得到充分证实,但人们对其在疾病活动期的参与仍知之甚少。在这里,我们检查了未经治疗的 MS 患者或高风险临床孤立综合征患者的脑脊液(CSF)和外周血(PB)B 细胞。通过流式细胞术,我们发现与 T 细胞相比,MRI 上有钆增强(Gd+)病变的患者的 CSF 淋巴细胞增多,其中 B 细胞不成比例地增加。CSF 和 PB B 细胞的 Ig 基因重链可变区(Ig-VH)库测序显示,鞘内和外周 B 细胞群之间存在克隆关系,这可能与 B 细胞向中枢神经系统迁移和在活跃的 MS 中激活相一致。此外,我们发现证据表明 B 细胞从外周旁观移民,这可能得到 CSF 和血液之间 CXCL13 梯度的支持。了解是什么引发 B 细胞迁移并归巢到中枢神经系统,最终可能有助于合理选择治疗策略,以限制 MS 的进展。

相似文献

1
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.
JCI Insight. 2017 Nov 16;2(22). doi: 10.1172/jci.insight.92724.
3
B cells undergo unique compartmentalized redistribution in multiple sclerosis.
J Autoimmun. 2011 Dec;37(4):289-99. doi: 10.1016/j.jaut.2011.08.003. Epub 2011 Sep 15.
4
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
Sci Transl Med. 2014 Aug 6;6(248):248ra106. doi: 10.1126/scitranslmed.3008930.
7
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
Neurology. 2009 Dec 8;73(23):2003-10. doi: 10.1212/WNL.0b013e3181c5b457.
8
Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
PLoS One. 2017 Aug 4;12(8):e0182462. doi: 10.1371/journal.pone.0182462. eCollection 2017.
9
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11064-9. doi: 10.1073/pnas.0402455101. Epub 2004 Jul 19.
10
High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
J Neuroimmunol. 2014 Nov 15;276(1-2):187-94. doi: 10.1016/j.jneuroim.2014.08.620. Epub 2014 Aug 27.

引用本文的文献

1
Multiple Sclerosis: A Story of the Interaction Between Gut Microbiome and Components of the Immune System.
Mol Neurobiol. 2025 Jun;62(6):7762-7775. doi: 10.1007/s12035-025-04728-5. Epub 2025 Feb 11.
2
CXCL13: a common target for immune-mediated inflammatory diseases.
Clin Exp Med. 2024 Oct 24;24(1):244. doi: 10.1007/s10238-024-01508-8.
4
Deciphering Autoimmune Diseases: Unveiling the Diagnostic, Therapeutic, and Prognostic Potential of Immune Repertoire Sequencing.
Inflammation. 2025 Apr;48(2):676-695. doi: 10.1007/s10753-024-02079-2. Epub 2024 Jun 25.
5
B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases.
Clin Rev Allergy Immunol. 2024 Feb;66(1):76-98. doi: 10.1007/s12016-024-08984-6. Epub 2024 Mar 9.
7
CD11c B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy.
Ann Clin Transl Neurol. 2024 Apr;11(4):926-937. doi: 10.1002/acn3.52009. Epub 2024 Feb 8.
8
Intruders or protectors - the multifaceted role of B cells in CNS disorders.
Front Cell Neurosci. 2024 Jan 10;17:1329823. doi: 10.3389/fncel.2023.1329823. eCollection 2023.
9
Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment.
Brain Commun. 2023 Aug 14;5(4):fcad218. doi: 10.1093/braincomms/fcad218. eCollection 2023.
10
Genetic variation in the immunoglobulin heavy chain locus shapes the human antibody repertoire.
Nat Commun. 2023 Jul 21;14(1):4419. doi: 10.1038/s41467-023-40070-x.

本文引用的文献

1
Onset of secondary progressive MS after long-term rituximab therapy - a case report.
Ann Clin Transl Neurol. 2016 Dec 20;4(1):46-52. doi: 10.1002/acn3.377. eCollection 2017 Jan.
2
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.
3
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21.
4
B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue.
JCI Insight. 2016 Dec 8;1(20):e87234. doi: 10.1172/jci.insight.87234.
5
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
Ann Clin Transl Neurol. 2016 Feb 1;3(3):166-79. doi: 10.1002/acn3.293. eCollection 2016 Mar.
7
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Mult Scler. 2015 Jul;21(8):967-8. doi: 10.1177/1352458515588583. Epub 2015 Jun 3.
8
MiXCR: software for comprehensive adaptive immunity profiling.
Nat Methods. 2015 May;12(5):380-1. doi: 10.1038/nmeth.3364.
9
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Neurology. 2015 Jul 7;85(1):18-28. doi: 10.1212/WNL.0000000000001587. Epub 2015 Apr 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验